Patient and disease characteristics
| Number of patients, N (%) | 233 | (100%) |
| Median age at diagnosis of primary disease, y (range) | 28 | (0.1-68) |
| Median age at UCBT, y (range) | 31 | (0.3-69) |
| Children (<18 y), n (%) | 84 | (36) |
| Adults (≥18 y), n (%) | 149 | (64) |
| Median age at diagnosis of SN, y (range) | 32.4 | (1-73) |
| Median age at last follow-up, y (range) | 36.2 | (1.6-75.4) |
| Males, n (%) | 123 | (53) |
| Positive recipient CMV serology, n (%) | 120 | (52) |
| Type of primary disease, n (%) | ||
| Nonmalignant | 34 | (15) |
| Malignant | 199 | (83) |
| Primary diagnosis, n (%) | ||
| Acute leukemia | 121 | (52) |
| MDS/MPD | 32 | (14) |
| Lymphoproliferative disorders | 45 | (19) |
| Histiocytic disorder | 3 | (1) |
| ST | 1 | (<1) |
| BM failure syndrome | 13 | (6) |
| Hemoglobinopathy | 3 | (1) |
| Primary immune deficiency | 7 | (3) |
| Inborn error of metabolism | 8 | (4) |
| Previous HCT, n (%) | 52 | (22) |
| MAC, n (%) | 126 | (54%) |
| ATG, n (%) | 157 | (67) |
| TBI, n (%) | 118 | (51) |
| Number of patients, N (%) | 233 | (100%) |
| Median age at diagnosis of primary disease, y (range) | 28 | (0.1-68) |
| Median age at UCBT, y (range) | 31 | (0.3-69) |
| Children (<18 y), n (%) | 84 | (36) |
| Adults (≥18 y), n (%) | 149 | (64) |
| Median age at diagnosis of SN, y (range) | 32.4 | (1-73) |
| Median age at last follow-up, y (range) | 36.2 | (1.6-75.4) |
| Males, n (%) | 123 | (53) |
| Positive recipient CMV serology, n (%) | 120 | (52) |
| Type of primary disease, n (%) | ||
| Nonmalignant | 34 | (15) |
| Malignant | 199 | (83) |
| Primary diagnosis, n (%) | ||
| Acute leukemia | 121 | (52) |
| MDS/MPD | 32 | (14) |
| Lymphoproliferative disorders | 45 | (19) |
| Histiocytic disorder | 3 | (1) |
| ST | 1 | (<1) |
| BM failure syndrome | 13 | (6) |
| Hemoglobinopathy | 3 | (1) |
| Primary immune deficiency | 7 | (3) |
| Inborn error of metabolism | 8 | (4) |
| Previous HCT, n (%) | 52 | (22) |
| MAC, n (%) | 126 | (54%) |
| ATG, n (%) | 157 | (67) |
| TBI, n (%) | 118 | (51) |
CMV, cytomegalovirus; MDS/MPD, myelodysplastic/myeloproliferative disease.